- All sections
- G - Physics
- G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
- G16B 15/30 - Drug targeting using structural data; Docking or binding prediction
Patent holdings for IPC class G16B 15/30
Total number of patents in this class: 685
10-year publication summary
8
|
4
|
7
|
40
|
39
|
65
|
123
|
167
|
149
|
13
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Genentech, Inc. | 3869 |
20 |
NEC Laboratories America, Inc. | 1041 |
20 |
DeepMind Technologies Limited | 904 |
15 |
Pythia Labs, Inc. | 14 |
14 |
Tencent Technology (Shenzhen) Company Limited | 14058 |
9 |
Flagship Pioneering Innovations VI, LLC. | 381 |
9 |
The Board of Trustees of the Leland Stanford Junior University | 6246 |
8 |
Regeneron Pharmaceuticals, Inc. | 3986 |
8 |
FUJIFILM Corporation | 28805 |
7 |
The Broad Institute, Inc. | 1709 |
7 |
X Development LLC | 1427 |
7 |
Cyclica Inc. | 13 |
7 |
Benevolentai Technology Limited | 63 |
7 |
NEC Oncoimmunity AS | 18 |
7 |
Fujitsu Limited | 18405 |
6 |
Ecole Polytechnique Federale de Lausanne (epfl) | 1503 |
6 |
Deargen Inc. | 25 |
6 |
International Business Machines Corporation | 60129 |
5 |
Centre National de La Recherche Scientifique | 10102 |
5 |
Massachusetts Institute of Technology | 9913 |
5 |
Other owners | 507 |